MedPath

Doxifluridine

Generic Name
Doxifluridine
Drug Type
Small Molecule
Chemical Formula
C9H11FN2O5
CAS Number
3094-09-5
Unique Ingredient Identifier
V1JK16Y2JP

Overview

Doxifluridine has been investigated for the treatment of Stomach Cancer.

Indication

主要用于乳腺癌、胃癌和大肠癌。

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Doxifluridine Capsules
国药准字H20000651
化学药品
胶囊剂
8/31/2020
Doxifluridine Capsules
国药准字H20020332
化学药品
胶囊剂
8/19/2024
Doxifluridine Capsules
国药准字H20010760
化学药品
胶囊剂
7/10/2020
Doxifluridine Capsules
国药准字H20050713
化学药品
胶囊剂
1/11/2020
Doxifluridine Capsules
国药准字H20030052
化学药品
胶囊剂
3/31/2020
Doxifluridine Capsules
国药准字H20041727
化学药品
胶囊剂
8/13/2020
Doxifluridine Capsules
国药准字H20010180
化学药品
胶囊剂
3/10/2020
Doxifluridine Tablets
国药准字H20031075
化学药品
片剂
5/22/2020
Doxifluridine Tablets
国药准字H20031267
化学药品
片剂
4/13/2020
Doxifluridine Dispersible Tablets
国药准字H20080306
化学药品
片剂
11/29/2022

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.